SEARCH

SEARCH BY CITATION

References

  • 1
    National Drugs and Poisons Schedule Committee. Record of Reasons 52nd Meeting 19–20 February 2008. Canberra ( AUST ) : Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
  • 2
    Medicines Classification Committee. Minutes of the December 2007 Medicines Classification Committee Meeting. Wellington ( NZ ) : New Zealand Medicines and Medical Devices Safety Authority; 2007.
  • 3
    Reay G. An Inquiry into Physical Dependence and Addiction to Prescription and Over-the-Counter Medication. London ( UK ) : All-Party Parliamentary Drug Misuse Group, 2007–2008 Parliamentary Session; 2008.
  • 4
    Analgesic Expert Group. Therapeutic Guidelines: Analgesic. Version 5. Updated September 2007. Melbourne ( AUST ) : Therapeutic Guidelines; 2011.
  • 5
    New Drugs. Aust Prescriber. 2002;25(4):98.
  • 6
    Dutch MJ. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med J Aust. 2008;188(1):567.
  • 7
    Frei MY, Nielsen S, Dobbin MDH, Tobin CL. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust. 2010;193(5):2946.
  • 8
    Ernest D, Chia M, Corallo CE. Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Crit Care Resusc. 2010;12(2):10910.
  • 9
    Ng JL, Morgan DJR, Loh NKM, Gan SK, Coleman PL, Ong GSY, et al. Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust. 2011;194(6):31316.
  • 10
    Page CB, Wilson PA, Foy A, Downes MA, Whyte IM, Isbister GK. Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust. 2011;194(11):61314.
  • 11
    McDonough MA. Misuse of codeine-containing combination analgesics. Med J Aust. 2011;194(9):486.
  • 12
    Karamatic R, Croese J, Roche E. Serious morbidity associated with misuse of over-the-counter codeine–ibuprofen analgesics. Med J Aust. 2011;195(9):516.
  • 13
    Mallett A, Lynch M, John GT, Healy H, Lust K. Ibuprofen-related renal tubular acidosis in pregnancy. Obstet Med. 2011;4:122.
  • 14
    Robinson GM, Robinson S, McCarthy P, Cameron C. Misuse of over-the-counter codeine-containing analgesics: dependence and other adverse effects. N Z Med J. 2010;123(1317):5964.
  • 15
    McAvoy BR, Dobbin MDH, Tobin CL. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J. 2011;124(1346):2933.
  • 16
    Evans C, Chalmers-Watson TA, Gearry RB. Combination NSAID-codeine preparations and gastrointestinal toxicity. N Z Med J. 2010;123(1324):923.
  • 17
    Chetty R, Baoku Y, Mildner R, Banerjee A, Vallance D, Haddon A, et al. Severe hypokalaemia and weakness due to Nurofen misuse. Ann Clin Biochem. 2003;40:4223.
  • 18
    Lambert AP, Close C. Life-threatening hypokalaemia from abuse of Nurofen Plus. J R Soc Med. 2005;98:21.
  • 19
    Good B, Ford C. Over the counter drugs can be highly addictive. BMJ. 2007;334:9178.
  • 20
    Dyer B, Martin J, Mitchell J, Sauven N, Gazzard B. Hypokalaemia in ibuprofen and codeine phosphate abuse. Int J Clin Pract. 2004;58(11):10612.
  • 21
    Ter A, Salha R, Vadamalai V, Soper C. Ibuprofen codeine combination precipitating severe hypokalaemia in a patient with pre-existing type 1 renal tubular acidosis (letter). NDT Plus. 2008;4:2701.
  • 22
    Blackstock M, Lee A. Hypokalaemia and renal tubular acidosis due to abuse of Nurofen Plus. Case Rep Crit Care. 2012:3. doi:10.11552012141505.
  • 23
    Nielsen S, Cameron J, Pahoki S. Over the Counter Codeine Dependence. Melbourne ( AUST ) : Turning Point Alcohol and Drug Centre, 2010.
  • 24
    Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Canberra ( AUST ) : AIHW; 2011.
  • 25
    Australian Instritute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Canberra ( AUST ) : AIHW; 2011.
  • 26
    Nicholas R, Lee N, Roche A. Pharmaceutical Drug Misuse Problems in Australia: Complex Issues, Balanced Responses. Adelaide ( AUST ) : Flinders University, National Centre for Education and Training on Addiction; 2011.
  • 27
    International Narcotics Control Board. INCB Annual Report Press Release: Urgent Action is Needed Against the Growing Problem of Prescription Drug Abuse [Internet]. Vienna ( AUT ) : INCB; 2010 [cited 2012 Oct 7]. Available from: http://www.incb.org/incb/en/press_releases_2010.html.
  • 28
    World Health Organization. Ensuring Balance in National Policies on Controlled Substances: Guidance for Availability and Accessibility of Controlled Substances. Geneva ( CHE ) : WHO; 2011.
  • 29
    Peterson GM. Selecting nonprescription analgesics. Am J Ther. 2005;12(1):6779.
  • 30
    ComLaw. Therapeutic Goods Act 1989. Canberra ( AUST ) : Commonwealth of Australia; 1989.
  • 31
    New Zealand Legislation. Medicines Act 1981. Wellington ( NZ ) : New Zealand Parliamentary Counsel Office; 1981.
  • 32
    United Kingdom Legislation. Medicines Act 1968. London ( UK ) : Her Majesty Government; 1968.
  • 33
    National Drugs and Poisons Schedule Committee. Record of Reasons, 56th Meeting 2009 June 16–17. Canberra ( AUST ) : Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2009.
  • 34
    National Drugs and Poisons Schedule Committee. Record of Reasons, 53rd Meeting 2008 June 17–18. Canberra ( AUST ) : Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
  • 35
    National Drugs and Poisons Schedule Committee. Record of Reasons, 54th Meeting 2008 October 14–15. Canberra ( AUST ) : Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
  • 36
    National Drugs and Poisons Schedule Committee. Record of Reasons, 55th Meeting 2009 February 17–18. Canberra ( AUST ) : Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2009.
  • 37
    Therapeutic Goods Administration. Codeine Rescheduling – Information for Sponsors [Internet]. Canberra ( AUST ) : Commonwealth Department of Health and Ageing; 2010 [cited 2010 Oct 12]. Available from: http://www.webcitation.org/5yvt07xzm.
  • 38
    Medicines and Healthcare Products Regulatory Agency. MHRA Public Assessment Report. Codeine and dihydrocodeine-containing medicines: minimising the risk of addiction. London ( UK ) : MHRA; 2009.
  • 39
    Medicines and Healthcare Products Regulatory Agency. Dear Healthcare Professional Letter: Updated Advice on Non-prescription Medicines Containing Codeine or Dihydrocodeine (DHC) [Internet]. London ( UK ) : MHRA; 2009 [cited 2010 Oct 1]. Available from: http://www.webcitation.org/5z82aAg4Y.
  • 40
    Medicines Classification Committee. Minutes of the December 2007 Medicines Classification Committee Meeting [Internet]. Wellington ( NZ ) : New Zealand Medicines and Medical Devices Safety Authority; 2007 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin14Dec2007.htm.
  • 41
    Medicines Classification Committee. Minutes of the May 2009 Medicines Classification Committee Meeting. Wellington ( NZ ) : New Zealand Medicines and Medical Devices Safety Authority; 2009 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin14May09.htm.
  • 42
    Medicines Classification Committee. Minutes of the November 2009 Medicines Classification Committee Meeting. Wellington ( NZ ) : New Zealand Medicines and Medical Devices Safety Authority; 2009 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin03Nov2009.htm.
  • 43
    Medicines Classification Committee. Minutes of the November 2008 Medicines Classification Committee Meeting. Wellington ( NZ ) : Medicines and Medical Devices Safety Authority; 2008 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin25Nov2008.htm.
  • 44
    Kriebel D, Tickner J. Reenergizing public health through precaution. Am J Public Health. 2001;91(9):13515.
  • 45
    Stosic R, Dunagan F, Palmer H, Fowler T, Adams I. Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use. Int J Pharm Pract. 2011;19(4):23645.
  • 46
    Nielsen S, Cameron J, Lee N. Characteristics of a non-treatment seeking sample of over-the-counter codeine users: implications for intervention and prevention. J Opioid Manag. 2011;7(5):36370.
  • 47
    Nielsen S, Tobin C, Dobbin M. OTC codeine: Examining the evidence for and against. Aust Pharm. 2012;31(3):23640.
  • 48
    Hazell L, Shakir S. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):38596.
  • 49
    Committee on Safety of Medicines. Availability of Codeine and Dihydrocodeine Containing OTC Analgesics. London ( UK ) : MHRA; 2005.
  • 50
    National Drugs and Poisons Schedule Committee. Poisons Standard 2008. Canberra ( AUST ) : Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
  • 51
    Department of Health and Ageing. Poisons Standard 2010. Canberra ( AUST ) : Commonwealth of Australia; 2010.
  • 52
    New Zealand Medicines and Medical Devices Safety Authority. Alerts/Letters: Changes to Classification and Labelling Requirements for Codeine-containing Medicines [Internet]. Wellington ( NZ ) : MEDSAFE; 2010 [cited 2010 Oct 1]. Available from: http://www.webcitation.org/5z86HKQnj.